Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -65.25% is 41% below its 5-year average of -46.24%, around the middle of its 5-year range (-103.31%–-10.01%).
6.95% above its 12-month average of -70.13%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -11.57%.
RETURN ON ASSETS (ROA)
-65.25%
RETURN ON ASSETS (ROA) AVG TTM
-70.13%
RETURN ON ASSETS (ROA) AVG 3Y
-63.89%
RETURN ON ASSETS (ROA) AVG 5Y
-46.24%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.95%
CURRENT VS 3Y AVG
-2.12%
CURRENT VS 5Y AVG
-41.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.09%
median of 854 covered companies
CURRENT VS SECTOR MEDIAN
-103.33%
vs the sector median at left
Korro Bio, Inc.
Market Cap
$96.65M
Return on Assets (ROA)
-65.25%
TTM Avg
-70.13%
3Y Avg
-63.89%
5Y Avg
-46.24%
Market Cap
$97.28M
Return on Assets (ROA)
-46.26%
TTM Avg
-55.26%
3Y Avg
-67.06%
5Y Avg
-56.22%
Market Cap
$99.01M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$99.23M
Return on Assets (ROA)
-206.78%
TTM Avg
-134.13%
3Y Avg
-143.93%
5Y Avg
-119.05%
Market Cap
$92.33M
Return on Assets (ROA)
-1.90%
TTM Avg
1.32%
3Y Avg
1.93%
5Y Avg
1.93%
Market Cap
$91.46M
Return on Assets (ROA)
-88.24%
TTM Avg
-139.34%
3Y Avg
-100.15%
5Y Avg
-71.92%
Market Cap
$90.32M
Return on Assets (ROA)
46.45%
TTM Avg
-49.63%
3Y Avg
-50.17%
5Y Avg
-40.85%
Market Cap
$102.64M
Return on Assets (ROA)
7.36%
TTM Avg
-1.10%
3Y Avg
-3.18%
5Y Avg
2.66%
Market Cap
$90.41M
Return on Assets (ROA)
-30.70%
TTM Avg
-50.88%
3Y Avg
-51.94%
5Y Avg
-48.05%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $96.65M | -65.25% | -70.13% | -63.89% | -46.24% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.28M | -46.26% | -55.26% | -67.06% | -56.22% |
| Conexeu Sciences Inc. (CNXU)vs › | $99.01M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.23M | -206.78% | -134.13% | -143.93% | -119.05% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.33M | -1.90% | 1.32% | 1.93% | 1.93% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.46M | -88.24% | -139.34% | -100.15% | -71.92% |
| Rallybio Corporation (RLYB)vs › | $90.32M | 46.45% | -49.63% | -50.17% | -40.85% |
| The Joint Corp. (JYNT)vs › | $102.64M | 7.36% | -1.10% | -3.18% | 2.66% |
| Equillium, Inc. (EQ)vs › | $90.41M | -30.70% | -50.88% | -51.94% | -48.05% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | -32.73% | -70.83% | -106.23% | -81.00% |
ROA
-65.3%
ROE
-103.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -103.31% |
| 2024-12-31 | -36.94% |
| 2023-12-31 | -36.62% |
| 2022-12-31 | -78.70% |
| 2021-12-31 | -11.85% |
| 2020-12-31 | -10.01% |
| 2019-12-31 | -8.40% |
| 2018-12-31 | -43.03% |
| 2017-12-31 | -102.27% |
